Pulmonology Medical News about P. aeruginosa

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Acquisition and eradication of P. aeruginosa in young children with CF
Breathe, 06/10/09

This study suggests that eradication of P. aeruginosa infection is achievable in young children with CF for up to 5 years (range 3–69 months) using combination i.v., oral and nebulised antibiotic therapy and is associated with reduced pulmonary inflammation 12 months after eradication.

<< Previous
Associated Factors and Cost of Inappropriate Hospital Admissions...

Next >>
Postpneumonectomy syndrome: rare, sometimes severe, but...

Procalcitonin Serum Concentration During Pneumocystis Jiroveci Colonization or Pseudomonas Aeruginosa Infection/Colonization in Lung Transplant Recipients
Transplantation Proceedings, 11/12/09 Relevance Score: 66%

MexT modulates virulence determinants in Pseudomonas aeruginosa independent of the MexEF-OprN efflux pump
Microbial Pathogenesis, 10/26/09 Relevance Score: 66%

An Outbreak of Post-Cataract Surgery Endophthalmitis Caused by Pseudomonas aeruginosa
Ophthalmology, 10/23/09 Relevance Score: 66%

Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms
Clinical Microbiology Reviews, 10/14/09 Relevance Score: 66%

In Vivo Efficacy of 1- and 2-Gram Human Simulated Prolonged Infusions of Doripenem against Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, 10/08/09 Relevance Score: 66%